2-Chlorodeoxyadenosine: lack of synergism with cyclosporine A and tacrolimus (FK 506).
New clinically useful drug, 2-chlorodeoxyadenosine (2-CdA), was found to be a potent immunosuppressant both in vitro and in vivo. The present study examines the in vitro interactions of classical immunosuppressive agents--FK 506 and Cyclosporine A (CsA) with 2-CdA at the level of T and B cells proliferation, expression receptor for interleukin 2 (R-IL-2) and Ig synthesis. No synergism between 2-CdA and either FK 506 or CsA was demonstrable.